Want to join the conversation?
$ESRX narrowed its 2016 adjusted EPS guidance to range of $6.33-6.43 from previous forecast of $6.31-6.43. This raises the mid-point from $6.37 to $6.38. The increased guidance range represents growth of 14-16% over 2015. $ESRX widened its 2016 diluted weighted average shares forecast to range of 632-640MM from prior range of 635-645MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.